Literature DB >> 22905747

Sodium channels and the neurobiology of epilepsy.

Megan Oliva1, Samuel F Berkovic, Steven Petrou.   

Abstract

Voltage-gated sodium channels (VGSCs) are integral membrane proteins. They are essential for normal neurologic function and are, currently, the most common recognized cause of genetic epilepsy. This review summarizes the neurobiology of VGSCs, their association with different epilepsy syndromes, and the ways in which we can experimentally interrogate their function. The most important sodium channel subunit of relevance to epilepsy is SCN1A, in which over 650 genetic variants have been discovered. SCN1A mutations are associated with a variety of epilepsy syndromes; the more severe syndromes are associated with truncation or complete loss of function of the protein. SCN2A is another important subtype associated with epilepsy syndromes, across a range of severe and less severe epilepsies. This subtype is localized primarily to excitatory neurons, and mutations have a range of functional effects on the channel. SCN8A is the other main adult subtype found in the brain and has recently emerged as an epilepsy gene, with the first human mutation discovered in a severe epilepsy syndrome. Mutations in the accessory β subunits, thought to modulate trafficking and function of the α subunits, have also been associated with epilepsy. Genome sequencing is continuing to become more affordable, and as such, the amount of incoming genetic data is continuing to increase. Current experimental approaches have struggled to keep pace with functional analysis of these mutations, and it has proved difficult to build associations between disease severity and the precise effect on channel function. These mutations have been interrogated with a range of experimental approaches, from in vitro, in vivo, to in silico. In vitro techniques will prove useful to scan mutations on a larger scale, particularly with the advance of high-throughput automated patch-clamp techniques. In vivo models enable investigation of mutation in the context of whole brains with connected networks and more closely model the human condition. In silico models can help us incorporate the impact of multiple genetic factors and investigate epistatic interactions and beyond. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22905747     DOI: 10.1111/j.1528-1167.2012.03631.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  50 in total

1.  Case-control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy.

Authors:  Larry Baum; Batoul Sadat Haerian; Ho-Keung Ng; Virginia C N Wong; Ping Wing Ng; Colin H T Lui; Ngai Chuen Sin; Chunbo Zhang; Brian Tomlinson; Gary Wing-Kin Wong; Hui Jan Tan; Azman Ali Raymond; Zahurin Mohamed; Patrick Kwan
Journal:  Hum Genet       Date:  2013-12-13       Impact factor: 4.132

2.  Physiological and genetic analysis of multiple sodium channel variants in a model of genetic absence epilepsy.

Authors:  M K Oliva; T C McGarr; B J Beyer; E Gazina; D I Kaplan; L Cordeiro; E Thomas; S D Dib-Hajj; S G Waxman; W N Frankel; S Petrou
Journal:  Neurobiol Dis       Date:  2014-03-19       Impact factor: 5.996

Review 3.  Sodium channels in astroglia and microglia.

Authors:  Laura W Pappalardo; Joel A Black; Stephen G Waxman
Journal:  Glia       Date:  2016-02-26       Impact factor: 7.452

4.  A missense mutation in SLC6A1 associated with Lennox-Gastaut syndrome impairs GABA transporter 1 protein trafficking and function.

Authors:  Kefu Cai; Jie Wang; Jaclyn Eissman; Juexin Wang; Gerald Nwosu; Wangzhen Shen; Hui-Ci Liang; Xiao-Jing Li; Hai-Xia Zhu; Yong-Hong Yi; Jeffrey Song; Dong Xu; Eric Delpire; Wei-Ping Liao; Yi-Wu Shi; Jing-Qiong Kang
Journal:  Exp Neurol       Date:  2019-06-06       Impact factor: 5.330

Review 5.  Resolving the Micro-Macro Disconnect to Address Core Features of Seizure Networks.

Authors:  Jordan S Farrell; Quynh-Anh Nguyen; Ivan Soltesz
Journal:  Neuron       Date:  2019-03-20       Impact factor: 17.173

6.  The phenotypic spectrum of SCN8A encephalopathy.

Authors:  Jan Larsen; Gemma L Carvill; Elena Gardella; Gerhard Kluger; Gudrun Schmiedel; Nina Barisic; Christel Depienne; Eva Brilstra; Yuan Mang; Jens Erik Klint Nielsen; Martin Kirkpatrick; David Goudie; Rebecca Goldman; Johanna A Jähn; Birgit Jepsen; Deepak Gill; Miriam Döcker; Saskia Biskup; Jacinta M McMahon; Bobby Koeleman; Mandy Harris; Kees Braun; Carolien G F de Kovel; Carla Marini; Nicola Specchio; Tania Djémié; Sarah Weckhuysen; Niels Tommerup; Monica Troncoso; Ledia Troncoso; Andrea Bevot; Markus Wolff; Helle Hjalgrim; Renzo Guerrini; Ingrid E Scheffer; Heather C Mefford; Rikke S Møller
Journal:  Neurology       Date:  2015-01-07       Impact factor: 9.910

7.  Nav1.1 modulation by a novel triazole compound attenuates epileptic seizures in rodents.

Authors:  John Gilchrist; Stacey Dutton; Marcelo Diaz-Bustamante; Annie McPherson; Nicolas Olivares; Jeet Kalia; Andrew Escayg; Frank Bosmans
Journal:  ACS Chem Biol       Date:  2014-03-31       Impact factor: 5.100

Review 8.  Defects at the crossroads of GABAergic signaling in generalized genetic epilepsies.

Authors:  Jing-Qiong Kang
Journal:  Epilepsy Res       Date:  2017-08-26       Impact factor: 3.045

9.  Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome.

Authors:  Heather E Olson; Dimira Tambunan; Christopher LaCoursiere; Marti Goldenberg; Rebecca Pinsky; Emilie Martin; Eugenia Ho; Omar Khwaja; Walter E Kaufmann; Annapurna Poduri
Journal:  Am J Med Genet A       Date:  2015-04-25       Impact factor: 2.802

10.  Human slack potassium channel mutations increase positive cooperativity between individual channels.

Authors:  Grace E Kim; Jack Kronengold; Giulia Barcia; Imran H Quraishi; Hilary C Martin; Edward Blair; Jenny C Taylor; Olivier Dulac; Laurence Colleaux; Rima Nabbout; Leonard K Kaczmarek
Journal:  Cell Rep       Date:  2014-12-04       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.